VP, Comparative Effectiveness Research
Jennifer Graff, PharmD, is the National Pharmaceutical Council's (NPC) vice president of comparative effectiveness research. In this role, she leads research and policy initiatives to advance the use of evidence-based medicine to inform health care decision-making. Her areas of focus include research and policy approaches to support the use of high-quality data and good research methods to enable all stakeholder to access, share, appraise and apply high-quality, real-world evidence to improve patient care.
Prior to joining NPC in 2009, Dr. Graff led strategic health economic and outcomes research activities at MedImmune and Pfizer Pharmaceuticals. She has authored over 15 peer-reviewed articles and presents frequently on policy issues affecting the biopharmaceutical industry. She currently serves as an associate editor of eGEMS and as a governing board member of the Agency for Healthcare Research and Quality's Registry of Patient Registries Web Forum.
Dr. Graff holds a Doctorate of Pharmacy from the University of Nebraska Medical Center, and completed a Health Outcomes and Pharmacoeconomics fellowship at the University of Michigan.